Detailed Information
Cited 3 time in 
Cited 3 time in 
Cited 3 time in
Metadata Downloads
Angiotensin converting enzyme inhibitors remain the first treatment of choice
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Oh, Pyung Chun | - |
| dc.contributor.author | Sakuma, Ichiro | - |
| dc.contributor.author | Hayashi, Toshio | - |
| dc.contributor.author | Koh, Kwang Kon | - |
| dc.date.available | 2020-02-28T02:44:28Z | - |
| dc.date.created | 2020-02-06 | - |
| dc.date.issued | 2016-03 | - |
| dc.identifier.issn | 1226-3303 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8512 | - |
| dc.description.abstract | Angiotensin converting enzyme (ACE) inhibitors (ACEIs) are beneficial and are strongly recommended for patients with acute myocardial infarction (MI) associated with heart failure, left ventricular systolic dysfunction, or preserved left ventricular systolic function. A number of clinical trials have demonstrated the benefits of ACEIs in such patients [1,2]. | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | KOREAN ASSOC INTERNAL MEDICINE | - |
| dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
| dc.title | Angiotensin converting enzyme inhibitors remain the first treatment of choice | - |
| dc.type | Article | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.identifier.wosid | 000372174600004 | - |
| dc.identifier.doi | 10.3904/kjim.2016.026 | - |
| dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, v.31, no.2, pp.237 - 241 | - |
| dc.identifier.kciid | ART002089190 | - |
| dc.description.isOpenAccess | N | - |
| dc.identifier.scopusid | 2-s2.0-84960127920 | - |
| dc.citation.endPage | 241 | - |
| dc.citation.startPage | 237 | - |
| dc.citation.title | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
| dc.citation.volume | 31 | - |
| dc.citation.number | 2 | - |
| dc.contributor.affiliatedAuthor | Oh, Pyung Chun | - |
| dc.contributor.affiliatedAuthor | Koh, Kwang Kon | - |
| dc.type.docType | Editorial Material | - |
| dc.subject.keywordPlus | ELEVATION MYOCARDIAL-INFARCTION | - |
| dc.subject.keywordPlus | RECEPTOR BLOCKERS | - |
| dc.subject.keywordPlus | INCREASE RISK | - |
| dc.subject.keywordPlus | RAMIPRIL | - |
| dc.relation.journalResearchArea | General & Internal Medicine | - |
| dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Koh, Kwang Kon
- College of Medicine (Department of Medicine)